Integrating Ayurvedic Therapies in Chronic Kidney Disease Management: A Case Report on Symptom Improvement and Renal Function Enhancement

Authors

  • Acharya Manish Director, Meditation Guru, Jeena Sikho Lifecare Limited, India
  • Gitika Chaudhary Senior Consultant, General Surgeon, BAMS, PGDIP, PGDGS, MS (Ayurveda), Jeena Sikho Lifecare Limited, India
  • Richa Senior Research officer, BAMS, PGDIP, CICR, CAIM, CMW, Jeena Sikho Lifecare Limited, India
  • Suyash Pratap Singh Medical Superintendent, BAMS, PGDIP, DNYT, CCMC, Jeena Sikho Lifecare limited Hospital Derabassi, Punjab, India
  • Manjeet Singh Consultant, BAMS, PGDIP, ACLS, CCDN, CICR, CAIM, Jeena Sikho Lifecare Limited Hospital, Derabassi, Punjab, India
  • Pooja Consultant, BAMS, PGDIP, DAGO, Jeena Sikho Lifecare Limited Hospital, Derabassi, Punjab, India

DOI:

https://doi.org/10.48165/aabr.2025.2.2.06

Keywords:

Ayurveda, Chronic Kidney Disease (CKD), Glomerular Filtration Rate, Hypertension, Itching, Panchkarma, Vrikk Rog

Abstract

Chronic kidney disease (CKD) affects 10–15% of adults globally and is often  underdiagnosed due to limitations in standard serum creatinine assessments.  This case report presents a 56-year-old male with a 1.5-year history of CKD and 5  years of hypertension, treated at Jeena Sikho Lifecare Limited Hospital, Derabassi,  with a comprehensive Ayurvedic regimen including medicines and Panchakarma  therapies. The patient showed marked improvement in multiple clinical  parameters: pedal oedema decreased from grade 4˚ to 1˚, pain resolved completely  (3/10 to 0/10), sleep quality improved from 3/10 to 7/10, and itching, initially rated  6/10, was fully alleviated. Vital signs stabilized, with blood pressure maintained  at 120/80 mmHg, and body weight reduced from 82 kg to 73 kg, reflecting  positive effects of lifestyle and dietary modifications. Laboratory investigations  demonstrated gradual improvement and stabilization, with haemoglobin ranging  from 7.1 to 9.3 gm/dL, urea decreasing from 200.85 mg/dL to 66.5 mg/dL,  creatinine improving from 7.25 mg/dL to 5.61 mg/dL, and uric acid declining  from 9.87 mg/dL to 6.87 mg/dL. Overall, the patient achieved normalization of  clinical and laboratory parameters, highlighting the potential of Ayurveda as a  safe, cost-effective, and integrative approach for managing CKD, particularly for  patients seeking holistic healthcare solutions. 

 

References

Razavian, M., Heeley, E. L., Perkovic, V., Zoungas, S., Weekes, A., Patel, A. A., Anderson, C. S., Chalmers, J. P., & Cass, A. (2012). Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrology Dialysis Transplantation, 27(4), 1396–1402.

Delanaye, P., Dubois, B., Cavalier, E., & Jouret, F. (2022). Diagnostic approach to chronic kidney disease. Revue Médicale de Liège, 77(4), 249–252. PMID: 35389010

Makino, H. (2009). Preface: New CKD guidebook from the Japanese Society of Nephrology. Clinical and Experimental Nephrology, 13(6), 533–534. https://doi.org/10.1007/s10157-009-0188-0

Sladen, R. N. (2011). Chronic kidney disease: The silent enemy? Anesthesia & Analgesia, 113(2), 251–252. https://doi.org/10.1213/ANE.0b013e318217f828

Van Biesen, W., Veys, N., Verbeke, F., & Vanholder, R. (2006). Chronic kidney disease: The Cinderella of general medicine. Epidemiology of and screening for CKD in Belgium. Acta Clinica Belgica, 61(6), 319–325. https://doi.org/10.1179/acb.2006.051

Firth, J. (2010). What is CKD? InnovAiT, 3(12), 726–732.

Mathew, T. (2011). Chronic kidney disease – an exemplar for collaboration between the clinic and the laboratory. Clinical Biochemistry Reviews, 32(2), 57–60.

Anupama, Y. J. (2022). ‘Kidney Health for All’ – Implications for India. Indian Journal of Kidney Diseases, 1(1), 8–12.

Nair, R. (2012). Chronic kidney disease – an overview. Kerala Medical Journal, 5(2), 58–62.

Debbarma, R. K., & Ray, D. (2014). Detection of chronic kidney disease in high risk groups attending in a tertiary care hospital of North East India. IOSR Journal of Dental and Medical Sciences, 13(5), 1–4.

Agarwal, S. K. (2005). Chronic kidney disease and its prevention in India. Kidney International, 68(Suppl. 98), S41–S45.

Hossain, S., & Batcha, M. S. (2021). Scientometric analysis of research productivity from Indian dialysis over the last twenty years in Web of Science. Collnet Journal of Scientometrics and Information Management, 15(2), 323–339.

Udayakumar, N. (2006). Chronic kidney disease in India: From a resident physician’s perspective. Postgraduate Medical Journal, 82(973), 697–698.

Menon, M., & Shukla, A. (2018). Understanding hypertension in the light of Ayurveda. Journal of Ayurveda and Integrative Medicine, 9(4), 302–307.

Patwardhan, K. (2012). The history of the discovery of blood circulation: Unrecognized contributions of Ayurveda masters. Advances in Physiology Education, 36(2), 77–82.

Srivastava, A. K., Negi, M., Vandana, & Painuly, P. (2024). A case study on Ayurvedic management of chronic kidney disease. International Journal of Advanced Research, 12(3), 707–712.

National Kidney Foundation. (2012). KDOQI clinical practice guideline for diabetes and CKD: 2012 update. American Journal of Kidney Diseases, 60(5), 850–886.

de Almeida Alvarenga, L., de Oliveira Leal, V., Borges, N. A., de Aguiar, A. S., Faxén-Irving, G., Stenvinkel, P., Lindholm, B., & Mafra, D. (2018). Curcumin – a promising nutritional strategy for chronic kidney disease patients. Journal of Functional Foods, 40, 715–721.

Santhosh, S., Pazhani, G. P., Arathi, M. S., & Manickam, S. (2023). Nephroprotective role of Boerhavia diffusa in renal disorders: A review. Research Journal of Pharmacy and Technology, 16(2), 962–968.

Jeyanthi, T., & Subramanian, P. (2009). Nephroprotective effect of Withania somnifera: A dose-dependent study. Renal Failure, 31(9), 814–821.

Jha, V. (2010). Herbal medicines and chronic kidney disease. Nephrology, 15, 10–17.

Chand, G. M., & Chand, T. A. (2015). Critical review on commonly used herbal drugs in CKD. Journal of Medicinal Plants Studies, 3(4), 44–47.

Charaka Samhita. Sutra Sthana, Chapter 3, Sutra 10. Sharma, A., & Das, B. (Eds.). (2008). Varanasi: Chaukhambha Orientalia.

Sushruta Samhita. Sutra Sthana, Chapter 12, Sutra 11. Bhide, V. P., & Misra, V. N. (Eds.). (2006). Varanasi: Chaukhambha Orientalia.

Acharya, M., Chaudhary, G., Singh, S. P., Singh, M., & Richa. (2024). Clinical evaluation of chronic kidney disease management: Integrating lifestyle modification and Ayurveda. International Journal of AYUSH, 13(10), 12–25.

Karna, A. K., Doddamani, S. A., & Medikeri, S. S. (2020). Concept of Pathyapathya with reference to Mutravaha Sroto Vikaras. Journal of Ayurveda and Integrated Medical Sciences, 4, 199–203.

Sharma, P. V., Sukla, V., & Tripathi, R. (2013). Sushrut Samhita Hindi Commentary. Delhi: Chaukhamba Sanskrit Pratisthan.

Shashidhar, S. S., & Pramodhkumar, N. (2024). Millets and its benefits according to Ayurveda. Journal of Ayurveda and Integrated Medical Sciences, 9(9), 231–235.

Bora, P., Ragaee, S., & Marcone, M. (2019). Characterisation of several types of millets as functional food ingredients. International Journal of Food Sciences and Nutrition, 70, 714–724.

Neelayathatchi, P., Neasri, T. M., & Sanwal, C. S. (2023). Ayurvedic perspective and clinical significance of millets. Journal of Ayurveda and Integrated Medical Sciences, 12, 161–174.

Pandey, A., Azad, A. S., Bhardwaj, A., Thakur, G., & Prakash, G. M. (n.d.). Shridhar University, Dayanand Ayurvedic College.

Dash, B., Acharya, R., & Pattajoshi, G. (2020). Matra basti the panacea: A narrative review. International Ayurvedic Medical Journal, 5, 2606–2611.

Choudhary, S., Kumari, I., Thakur, S., Kaurav, H., & Chaudhary, G. (2021). Brahmi (Bacopa monnieri) – a potential Ayurvedic cognitive enhancer and neuroprotective herb. International Journal of Ayurveda and Pharma Research, 41–49.

Ghore, D. J., Patil, A., & Chitrakar, M. (2021). Systemic review on benefits of Ksheerbala Taila. NVEO – Natural Volatile and Essential Oils Journal, 9629–9643.

Rahaman, S. M., Sarkar, N. C., Taher, M., Pandey, A., Bank, S. R., Banerjee, A., & Biswas, T. K. (2024). Standard Ayurvedic management for chronic kidney disease. Science and Culture.

Upadhyay, A. K., Kumar, K., Kumar, A., & Mishra, H. S. (2010). Tinospora cordifolia (Guduchi) – validation of Ayurvedic pharmacology. International Journal of Ayurveda Research, 1(2), 112.

McPhee, G. M., Downey, L. A., Wesnes, K. A., & Stough, C. (2021). Neurocognitive effects of Bacopa monnieri. Frontiers in Aging Neuroscience, 13, 638109.

Shalini, V. T., Neelakanta, S. J., & Sriranjini, J. S. (2021). Neuroprotection with Bacopa monnieri. Molecular Biology Reports, 48(3), 2653–2668.

Bairagi, B. A., Gadkari, P. U., & More, M. S. Clinical evaluation of Varunadi Taila Vrikka Basti in renal calculi.

Brodovicz, K. G., McNaughton, K., Uemura, N., Meininger, G., Girman, C. J., & Yale, S. H. (2009). Reliability and feasibility of methods to quantitatively assess peripheral edema. Clinical Medicine & Research, 7(1–2), 21–31.

Stretanski, M. F., Stinocher, S., & Grandhe, S. (2025). Pain assessment. In StatPearls. Treasure Island (FL): StatPearls Publishing.

Mujahid, M., Nasir, K., Qureshi, R., Dhrolia, M., & Ahmad, A. (2022). Quality of sleep in CKD and ESRD. Cureus, 14(4), e23862.

Verduzco, H. A., & Shirazian, S. (2020). CKD-associated pruritus. Kidney International Reports, 5(9), 1387–1402.

Rajshekar, N., & Shettar, P. (2021). Combined effectiveness of Anubhuta Kashaya and Kaishora Guggulu in CKD. International Journal of Ayurveda and Pharma Research, 9(9), 11–20.

Raut, N. R., Mishra, B. R., & Mishra, A. B. (2023). Concept of Hita-Ahita Ahara. Journal of Ayurveda and Integrated Medical Sciences, 8(5), 154–158.

Schrauben, S. J., Apple, B. J., & Chang, A. R. (2022). Modifiable lifestyle behaviors and CKD progression. Kidney360, 3(4), 752–778.

Pandey, R. K., Arya, T. V., Kumar, A., & Yadav, A. (2017). Effects of yoga on CKD. International Journal of Yoga, 10(1), 3–8.

Kramer, H. (2019). Diet and chronic kidney disease. Advances in Nutrition, 10(Suppl_4), S367–S379.

Jacob, J., Krishnan, V., Antony, C., et al. (2024). Nutrition and therapeutic potential of millets. Frontiers in Nutrition, 11, 1346869.

Bouby, N., Clark, W. F., Roussel, R., Taveau, C., & Wang, C. J. (2014). Hydration and kidney health. Obesity Facts, 7(Suppl 2), 19–32.

Cases, A., Cigarrán-Guldrís, S., Mas, S., & Gonzalez-Parra, E. (2019). Vegetable-based diets for CKD. Nutrients, 11(6), 1263.

Kirkman, D. L., Lennon-Edwards, S., & Edwards, D. G. (2014). Role of exercise in CKD. Journal of Renal Nutrition, 24(6), e51–e53.

Chu, G., Gois, P. F., & Viecelli, A. (2025). Role of sleep in CKD prevention. Kidney International Reports, 10(6), 1613–1615.

Kaushik, R., Jain, J., Khan, A. D., & Rai, P. (2018). Trikatu – bioavailability enhancers. International Journal of Green Pharmacy, 12, S437–S441.

Mulke, V. G., & Ghotankar, A. M. (2020). Therapeutic uses of Chitraka. World Journal of Pharmaceutical and Medical Research, 6(4), 56–59.

Singh, P., Srivastava, M. M., & Khemani, L. D. (2009). Renoprotective effects of Andrographis paniculata. Upsala Journal of Medical Sciences, 114(3), 136–139.

Almeleebia, T. M., Alsayari, A., & Wahab, S. (2022). Picrorhiza kurroa review. Molecules, 27(23), 8316.

Kumar, K. P., Bhowmik, D., Chiranjib, Biswajit, & Chandira, M. (2010). Swertia chirata: Medicinal uses. Journal of Chemical and Pharmaceutical Research, 2(1), 262–266.

Choudhary, S., Kaurav, H., M., S., & Chaudhary, G. (2021). Daruharidra (Berberis aristata) review. International Journal of Research in Applied Science & Biotechnology, 8, 98–106.

Meher, S. K., Mukherjee, P. K., Banerjee Chaudhury, S. K., Marjit, B., & Shaw, B. P. (2016). Renal protective effect of Gokshura and Varuna. Research Journal of Pharmacology and Pharmacodynamics, 8(2), 75–82.

Zaman, R., Jafri, M., Ahmad, G., & Sofi, G. (2017). Nephroprotective effect of Cichorium intybus. International Journal of PharmaceuticalSciences and Research, 6, 337–341.

Mishra, P. K., Bhaskar, M., & Pandey, K. (2022). Ayurvedic drug review of Bhoo-Aamalaki. International Journal of Ayurvedic Herbal Medicine, 25, 54–61.

Joladarashi, D., Chilkunda, N. D., & Salimath, P. V. (2012). Tinospora cordifolia and kidney protection. Journal of Nutritional Science, 1, e7.

Vasant, R. A., & Narasimhacharya, A. V. (2012). Amla as hepato-renal protective agent. Journal of Pharmacy and Bioallied Sciences, 4(3), 250–254.

Babar, T., & Gokhale, V. (2021). Haritaki—an Ayurvedic literature review. International Journal of Science and Research, 10, 22.

Grunz-Borgmann, E., Mossine, V., Fritsche, K., & Parrish, A. R. (2015). Ashwagandha attenuates inflammatory activation. BMC Complementary and Alternative Medicine, 15, 434.

Jambi, E. J., & Alshubaily, F. A. (2022). Shilajit and renal protection. Saudi Journal of Biological Sciences, 29(9), 103393.

Seriana, I., Akmal, M., Darusman, D., Wahyuni, S., Khairan, K., & Sugito, S. (2021). Neem leaf extract and kidney function. Scientific WorldJournal, 2021, 7970424.

Singh, B. P., Dadhich, O. P., & Deepa, A. (2017). Medicinal uses of Manjistha. International Journal of Advanced Research, 5, 1394–1401.

Shaikh, H. S., & Shaikh, S. S. (2021). Babchi (Psoralea corylifolia) review. Asian Journal of Pharmaceutical Technology, 11(3), 238–244.

Kim, J., Lee, J., Kim, K. N., Oh, K. H., Ahn, C., Lee, J., Kang, D., & Park, S. K. (2018). Dietary mineral intake and CKD. International Journal of Environmental Research and Public Health, 15(6), 1070. doi: 10.3390/ijerph15061070. PMID: 29795052; PMCID: PMC6025644.

Published

2025-12-09

How to Cite

Integrating Ayurvedic Therapies in Chronic Kidney Disease Management: A Case Report on Symptom Improvement and Renal Function Enhancement . (2025). Advances in Applied Biological Research, 2(2), 49-66. https://doi.org/10.48165/aabr.2025.2.2.06